🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07426276
Enrolling by invitation Not applicable

Evaluating the Effect of Combined Parent Training Plus Speech Therapy on Children With Speech Development Disorder.

NCT07426276 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-01-10
Last updated
2026-02-23

Condition(s) studied

Developmental Language Disorder (DLD)

Investigational drug(s) / intervention(s)

Assisted speech therapy intervention + parent trainingstandard speech therapy

Assisted speech therapy intervention + parent training: The intervention was tailored to individual needs and aimed at improving verbal expression, communicative initiative, and social engagement. Each child receives therapy for a period of 16 weeks, for a total of 32 sessions, twice a week, with each session lasting 45 minutes and in addition 16 sessions of parent traning once a week for 45 minutes.Intervention sessions included tasks designed to engage the child in verbal and social interactions, (such as naming objects, answering questions and performing gestures) to improve verbal expression communicative intention and social engagement, in parallel the parents once a week participate in a parent training session with the aim of supporting and directing them to learn strategies to improve interaction with the child and facilitate communicative-linguistic development

standard speech therapy: Therapy followed established protocols and was adapted to meet the specific needs of the children. Each child received therapy for a period of 16 weeks (twice a week), for a total of 32 sessions.• Standard therapeutic approaches included exercises to improve verbal communication and social engagement, such as object naming, sentence construction and comprehension tasks. Therapists adapted the intervention to the individual communication goals of each 45-minute session.

Study summary

Language is an extremely complex cognitive function that, in situations of typical development, i.e. in the absence of deficits or environmental risk, is generally acquired with apparent ease and naturalness (Kuhl, 2010).

The first 1,000 days of life are considered a key time window in which children's developmental trajectories and future outcomes are shaped. During this period, it is crucial to provide children with nurturing experiences such as responsive care and appropriate learning opportunities (Britto et al., 2017).

Most children learn communication skills (e.g., pointing, gesturing) and language skills (e.g., saying words, following instructions) from high-quality interactions with parents and caregivers. However, some children may have language learning difficulties for a variety of reasons, including genetic, neurological and environmental.

Not all children necessarily follow the stages outlined: some present delayed language development. The early identification and diagnosis of the language disorder is therefore very important as this deficit can have a negative impact on the child's subsequent development of skills, the way he/she relates and subsequent acquisition skills in primary school.

This research aims to assess whether parents, guided and monitored by the speech therapist and psychologist through parental training, can try out specific and effective strategies that enable them to become a facilitating model for the child's communicative-linguistic learning, thereby also improving their quality of life.

Eligibility

Sex
ALL
Min age
3 Years
Max age
5 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of 'Developmental Language Disorders' (DLD) * Age between 3 and 5 years. * Signature of informed consent by parents and/or legal guardians. Exclusion Criteria: * No sensory impairment or another medical or neurological condition (ADHD, Autism, Deafness, Mental Retardation \<70); * Significant medical conditions that could interfere with participation in the study. * Failure to sign informed consent by parents and/or legal guardians.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS Neurolesi Bonino Pulejo, Messina,, Messina, Messina 98124 Messina Messina

More IRCCS Centro Neurolesi Bonino Pulejo trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07426276 on ClinicalTrials.gov ↗ ← All trials in Italy